Refractory Childhood Hodgkin Lymphoma

7 clinical trials · Condition

Record	Firm	Date
Ex Vivo Drug Sensitivity Testing and Mutation Profiling (NCT03860376)	Florida International University	2019-02-21
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01780662)	National Cancer Institute (NCI)	2013-01-31
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT01008462)	Fred Hutchinson Cancer Center	2010-03-18
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma (NCT00900250)	Children's Oncology Group	2006-10-23
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00027820)	Fred Hutchinson Cancer Center	2001-08-01
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma (NCT00005803)	Fred Hutchinson Cancer Center	1999-09-01

Every clearance here is in the API, with alerts when new ones post.